MLC1 and myasthenia gravis: During the stormy course of MG requiring cyclophosphamide and rituximab infusions, leukocytes remained >3 × 109/L, polymorphs >2 × 109/L, lymphocytes ≥0.7 × 109/L, CD4+ ~222/mm3, and VL-LDL.